These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7521421

  • 1. [Clinical study of retreatment of chronic hepatitis C with interferon (IFN) for non-complete responders on initial treatment].
    Toyoda H, Nakano S, Kumada T.
    Nihon Rinsho; 1994 Jul; 52(7):1798-803. PubMed ID: 7521421
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].
    Sata M, Tanikawa K.
    Nihon Rinsho; 1994 Jul; 52(7):1804-9. PubMed ID: 7521422
    [Abstract] [Full Text] [Related]

  • 4. Host and viral characteristics affecting the response to interferon therapy in chronic hepatitis C.
    Laurent-Puig P, Dussaix E, Altman C, Laval C, Stuyver L, Wilber JC, Babany G, Chopineau S, Bedossa P, Brocheriou I.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):335-40. PubMed ID: 7541297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E.
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR.
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [Abstract] [Full Text] [Related]

  • 10. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
    Iwabuchi S, Yoshida H, Fukui S.
    Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Jul; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S, Suzuki F, Hosaka T, Akuta N, Someya T, Kobayashi M, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [Abstract] [Full Text] [Related]

  • 14. [Examination in clinical course of HCV in interferon treatment].
    Kumada H.
    Nihon Rinsho; 1994 Jul; 52(7):1832-5. PubMed ID: 7521426
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [Abstract] [Full Text] [Related]

  • 18. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F, Sata M, Uchimura Y, Suzuki H, Tanikawa K.
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J.
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jul; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.